Epithelial Organotypic Cultures: A Viable Model to Address Mechanisms of Carcinogenesis by Epitheliotropic Viruses

Imagem de Miniatura
Arquivos
art_TERMINI_Epithelial_Organotypic_Cultures_A_Viable_Model_to_Address_2018.PDF (1.14 MB)
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2018
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BENTHAM SCIENCE PUBL LTD
Autores
BOCCARDO, Enrique
Citação
CURRENT TOPICS IN MEDICINAL CHEMISTRY, v.18, n.4, p.246-255, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
In vitro culture of primary or established cell lines is one of the leading techniques in many areas of basic biological research. The use of pure or highly enriched cultures of specific cell types obtained from different tissues and genetics backgrounds has greatly contributed to our current understanding of normal and pathological cellular processes. Cells in culture are easily propagated generating an almost endless source of material for experimentation. Besides, they can be manipulated to achieve gene silencing, gene overexpression and genome editing turning possible the dissection of specific gene functions and signaling pathways. However, monolayer and suspension cultures of cells do not reproduce the cell type diversity, cell-cell contacts, cell-matrix interactions and differentiation pathways typical of the three-dimensional environment of tissues and organs from where they were originated. Therefore, different experimental animal models have been developed and applied to address these and other complex issues in vivo. However, these systems are costly and time consuming. Most importantly the use of animals in scientific research poses moral and ethical concerns facing a steadily increasing opposition from different sectors of the society. Therefore, there is an urgent need for the development of alternative in vitro experimental models that accurately reproduce the events observed in vivo to reduce the use of animals. Organotypic cultures combine the flexibility of traditional culture systems with the possibility of culturing different cell types in a 3D environment that reproduces both the structure and the physiology of the parental organ. Here we present a summarized description of the use of epithelial organotypic for the study of skin physiology, human papillomavirus biology and associated tumorigenesis.
Palavras-chave
Epithelial organotypic cultures, Rafts, HPV, HPV-mediated carcinogenesis, virus
URI
https://observatorio.fm.usp.br/handle/OPI/27094
Referências
  1. Akgul B, 2005, CANCER RES, V65, P2216, DOI 10.1158/0008-5472.CAN-04-1952
  2. Alameda JP, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.82
  3. Anacker D., 2012, J VIS EXP
  4. Banerjee NS, 2006, J VIROL, V80, P6517, DOI 10.1128/JVI.02499-05
  5. Bechtel M, 2012, FASEB J, V26, P3637, DOI 10.1096/fj.11-194597
  6. BEDELL MA, 1991, J VIROL, V65, P2254
  7. BELL E, 1983, J INVEST DERMATOL, V81, pS2, DOI 10.1111/1523-1747.ep12539993
  8. BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
  9. BLANTON RA, 1991, AM J PATHOL, V138, P673
  10. Boccardo E, 2004, VIROLOGY, V328, P233, DOI 10.1016/j.virol.2004.07.026
  11. Boccardo E, 2010, CARCINOGENESIS, V31, P521, DOI 10.1093/carcin/bgp333
  12. Bodily JM, 2011, J VIROL, V85, P8852, DOI 10.1128/JVI.00664-11
  13. Bosch X, 2013, VACCINE, V31, P11
  14. Bowser BS, 2011, J VIROL, V85, P4982, DOI 10.1128/JVI.00133-11
  15. Boxman ILA, 2001, J INVEST DERMATOL, V117, P1397, DOI 10.1046/j.0022-202x.2001.01602.x
  16. Breitkreutz D, 2004, J CELL SCI, V117, P2611, DOI 10.1242/jcs.01127
  17. Valdano MB, 2016, J GEN VIROL, V97, P453, DOI 10.1099/jgv.0.000364
  18. CHENG S, 1995, GENE DEV, V9, P2335, DOI 10.1101/gad.9.19.2335
  19. CHOO KB, 1987, VIROLOGY, V161, P259, DOI 10.1016/0042-6822(87)90195-4
  20. Cichon AC, 2013, ONCOTARGET, V4, P1103, DOI 10.18632/oncotarget.1078
  21. Cardeal LBD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033585
  22. DELVENNE P, 1995, AM J PATHOL, V146, P589
  23. Demers GW, 1996, J VIROL, V70, P6862
  24. DOLLARD SC, 1992, GENE DEV, V6, P1131, DOI 10.1101/gad.6.7.1131
  25. DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532
  26. Fang L, 2006, VIROLOGY, V347, P28, DOI 10.1016/j.virol.2005.10.043
  27. Flores ER, 1999, VIROLOGY, V262, P344, DOI 10.1006/viro.1999.9868
  28. Frattini MG, 1997, J VIROL, V71, P7068
  29. Frattini MG, 1996, P NATL ACAD SCI USA, V93, P3062, DOI 10.1073/pnas.93.7.3062
  30. FUCHS E, 1981, CELL, V25, P617, DOI 10.1016/0092-8674(81)90169-0
  31. Genovese NJ, 2008, J VIROL, V82, P4862, DOI 10.1128/JVI.01202-07
  32. Giannini SL, 2002, INT J CANCER, V97, P654, DOI 10.1002/ijc.10084
  33. Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513
  34. GREEN H, 1982, MOL CELL BIOL, V2, P1115, DOI 10.1128/MCB.2.9.1115
  35. HALBERT CL, 1992, J VIROL, V66, P2125
  36. Halfter W, 2015, FEBS J, V282, P4466, DOI 10.1111/febs.13495
  37. Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
  38. Herman L, 2007, CANCER IMMUNOL IMMUN, V56, P1087, DOI 10.1007/s00262-006-0255-2
  39. Howley P. M., 2013, FIELDS VIROLOGY, P1662
  40. Hubert P, 2004, ANTIMICROB AGENTS CH, V48, P4342, DOI 10.1128/AAC-48.11.4342-4348.2004
  41. Hubert P, 1999, AM J PATHOL, V154, P775, DOI 10.1016/S0002-9440(10)65324-2
  42. Hubert P, 2007, FASEB J, V21, P2765, DOI 10.1096/fj.06-7646com
  43. HUIBREGTSE JM, 1991, EMBO J, V10, P4129
  44. HUMMEL M, 1992, J VIROL, V66, P6070
  45. International Agency for the Research on Cancer, HUM PAP
  46. Jacobs N, 1998, VIRCHOWS ARCH, V432, P323, DOI 10.1007/s004280050173
  47. Kabsch K, 2004, INTERVIROLOGY, V47, P48, DOI 10.1159/000076642
  48. KOPAN R, 1987, J CELL BIOL, V105, P427, DOI 10.1083/jcb.105.1.427
  49. Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802
  50. KREIDER JW, 1987, J VIROL, V61, P590
  51. Lee JH, 2004, P NATL ACAD SCI USA, V101, P2094, DOI 10.1073/pnas.0308615100
  52. Lee SA, 2011, J BIOL CHEM, V286, P13550, DOI 10.1074/jbc.M110.181065
  53. Marionnet C, 2006, J INVEST DERMATOL, V126, P971, DOI 10.1038/sj.jid.5700230
  54. Massi D, 2012, ADV EXP MED BIOL, V727, P131, DOI 10.1007/978-1-4614-0899-4_10
  55. Mathes SH, 2014, ADV DRUG DELIVER REV, V69, P81, DOI 10.1016/j.addr.2013.12.006
  56. MCCANCE DJ, 1988, P NATL ACAD SCI USA, V85, P7169, DOI 10.1073/pnas.85.19.7169
  57. McLaughlin-Drubin ME, 2004, VIROLOGY, V322, P213, DOI 10.1016/j.virol.2004.02.011
  58. McLaughlin-Drubin ME, 2003, VIROLOGY, V312, P1, DOI 10.1016/S0042-6822(03)00312-X
  59. MERRICK DT, 1992, AM J PATHOL, V140, P167
  60. MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879
  61. Meyers C, 1997, J VIROL, V71, P7381
  62. Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115
  63. Nakahara T, 2005, J VIROL, V79, P13150, DOI 10.1128/JVI.79.20.13150-13165.2005
  64. Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006
  65. Nischt R, 2007, J INVEST DERMATOL, V127, P545, DOI 10.1038/sj.jid.5700562
  66. Ojeh N, 2008, J CELL SCI, V121, P2705, DOI 10.1242/jcs.025643
  67. Ozbun MA, 1997, J VIROL, V71, P5161
  68. Ozbun MA, 2002, J GEN VIROL, V83, P2753, DOI 10.1099/0022-1317-83-11-2753
  69. Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109
  70. Pinheiro C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-751
  71. PRUNIERAS M, 1983, J INVEST DERMATOL, V81, pS28, DOI 10.1111/1523-1747.ep12540324
  72. Quint KD, 2015, J PATHOL, V235, P342, DOI 10.1002/path.4425
  73. RADER JS, 1990, ONCOGENE, V5, P571
  74. Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427
  75. Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200
  76. SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8
  77. SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3
  78. Seitz CS, 2000, CANCER RES, V60, P4085
  79. Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307
  80. Shabtai Y, 2016, BIOCHEM J, V473, P1423, DOI 10.1042/BCJ20160101
  81. Song HB, 2010, VIRUS RES, V147, P113, DOI 10.1016/j.virusres.2009.10.019
  82. Southern SA, 2001, CANCER RES, V61, P4858
  83. Steenbergen RDM, 1998, J VIROL, V72, P749
  84. STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702
  85. STOLER MH, 1990, J VIROL, V64, P3310
  86. Straub E, 2014, J VIROL, V88, P937, DOI 10.1128/JVI.02296-13
  87. Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017
  88. Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803
  89. Wang HK, 2009, GENE DEV, V23, P181, DOI 10.1101/gad.1735109
  90. Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010
  91. WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286
  92. Wilson R, 2005, J VIROL, V79, P6732, DOI 10.1128/JVI.79.11.6732-6740.2005
  93. Yoneda K, 2012, J INVEST DERMATOL, V132, P1206, DOI 10.1038/jid.2011.460
  94. Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105
  95. Zheng ZM, 2006, FRONT BIOSCI, V11, P2286, DOI 10.2741/1971

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - LIM/24